WallStreetZenWallStreetZen

NYSE: TARO
Taro Pharmaceutical Industries Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TARO past earnings growth

How has TARO's earnings growth performed historically?
Company
0%
Industry
13.39%
Market
61.16%
TARO's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
TARO's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
TARO's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

TARO past revenue growth

How has TARO's revenue growth performed historically?
Company
7.23%
Industry
10.23%
Market
16.96%
TARO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TARO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TARO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TARO earnings and revenue history

Current Revenue
$610.8M
Current Earnings
$45.7M
Current Profit Margin
7.5%
TARO's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

TARO Return on Equity

Current Company
2.6%
Current Industry
15.4%
Current Market
188%
TARO's Return on Equity (2.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TARO announces earnings.

TARO Return on Assets

Current Company
2.1%
Current Industry
3.4%
TARO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TARO Return on Capital Employed

Current Company
4.16%
Current Industry
5.1%
TARO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TARO vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TARO$610.83MN/A$45.70M-1.69%-31.12%
AVDL$27.96M-$149.13M-$160.28M-22.99%N/A
SUPN$607.52M$90.04M$1.32M+8.24%-60.69%
DVAX$232.28M$9.67M-$6.39M+95.19%N/A
TLRY$743.25M-$186.62M-$351.95M+30.54%N/A
View Top Pharmaceutical Stocks

TARO earnings dates

Next earnings date
May 21, 2024

Taro Pharmaceutical Industries Earnings & Revenue FAQ

What were TARO's earnings last quarter?

On Invalid Date, Taro Pharmaceutical Industries (NYSE: TARO) reported Q4 2023 earnings per share (EPS) of $0.54, up 184.21% year over year. Total Taro Pharmaceutical Industries earnings for the quarter were $20.21 million. In the same quarter last year, Taro Pharmaceutical Industries's earnings per share (EPS) was $0.19.

If you're new to stock investing, here's how to buy Taro Pharmaceutical Industries stock.

What was TARO's earnings growth in the past year?

As of Q2 2024, Taro Pharmaceutical Industries's earnings has grown 0% year over year. This is 13.39 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 13.39%. Taro Pharmaceutical Industries's earnings in the past year totalled $45.70 million.

What is TARO's earnings date?

Taro Pharmaceutical Industries's earnings date is Invalid Date. Add TARO to your watchlist to be reminded of TARO's next earnings announcement.

What was TARO's revenue last quarter?

On Invalid Date, Taro Pharmaceutical Industries (NYSE: TARO) reported Q4 2023 revenue of $157.15 million up 12.89% year over year. In the same quarter last year, Taro Pharmaceutical Industries's revenue was $139.20 million.

What was TARO's revenue growth in the past year?

As of Q2 2024, Taro Pharmaceutical Industries's revenue has grown 7.23% year over year. This is 2.99 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.23%. Taro Pharmaceutical Industries's revenue in the past year totalled $610.83 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.